BPC-157
Investigational; no FDA-approved therapeutic indication
Evidence: Insufficient human evidence
Administration: No approved route
Read Review →Evidence and regulatory context for peptide-based treatments connected to recovery.
TB-500
Investigational; no FDA-approved therapeutic indication
Evidence: Very limited human evidence
Administration: No approved route
Read Review →Established / approved options
No peptide is ranked here as a general recovery treatment without an approved indication and sufficient evidence.
Being researched
BPC-157 and TB-500 are commonly marketed for recovery, but they are unapproved and evidence remains limited or investigational.
How to use this page
Established options appear before experimental compounds. Goal relevance never overrides regulatory status or evidence quality.
Next step
Open the relevant treatment review for sources, risks, contraindications, and evidence gaps.
MyPeptideQuest
Information only. Not medical advice. No dosing or self-treatment instructions are provided.